Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

Ever bite into a supermarket tomato and wonder where all the flavor went? You're not imagining things. That watery, cardboard ...

If you have been wondering whether CRISPR Therapeutics at around $57 a share is a bargain or a bubble, you are not alone. This stock sits at the crossroads of high science and high expectations. The ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

This list exemplifies the hard work in science over this past year, not simply in the lab but where it matters.

CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

Spaceflight, genetic tinkering, and the psychological implications of technological acceleration are explored with accuracy ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...

A rare disease mom and scientist shares on the "First Opinion Podcast" how she serves as a translator between her two ...